Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ortho Clinical Diagnostics Holdings plc (OCDX)

17.63   0.16 (0.92%) 12-31 19:00
Open: 17.68 Pre. Close: 17.47
High: 17.71 Low: 17.36
Volume: 789,491 Market Cap: 0(M)

Technical analysis

as of: 2022-11-18 4:23:17 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 20.68     One year: 24.16
Support: Support1: 17.49    Support2: 17.36
Resistance: Resistance1: 17.7    Resistance2: 20.68
Pivot: 17.62
Moving Average: MA(5): 17.62     MA(20): 17.62
MA(100): 17.62     MA(250): 17.97
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 77.1     %D(3): 77.1
RSI: RSI(14): 49.3
52-week: High: 21.52  Low: 16.04
Average Vol(K): 3-Month: 789 (K)  10-Days: 789 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ OCDX ] has closed Bollinger Bands are 0% narrower than normal.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.75 - 17.84 17.84 - 17.91
Low: 17.12 - 17.24 17.24 - 17.33
Close: 17.46 - 17.64 17.64 - 17.79

Company Description

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Headline News

Tue, 21 Mar 2023
QuidelOrtho Corporation (QDEL) Stock Price Today, Quote & News - Seeking Alpha

Tue, 13 Dec 2022
Big Three Lead From The Front With Medtech Back On Solid Growth ... - In Vivo

Fri, 27 May 2022
Quidel, Ortho Clinical Diagnostics combine to form diagnostics ... - Mass Device

Mon, 23 May 2022
Merger Arbitrage Mondays: Carlyle to Acquire Defense Contractor ... - Seeking Alpha

Wed, 04 May 2022
Ortho Clinical Diagnostics Reports First Quarter 2022 Results - GlobeNewswire

Wed, 16 Feb 2022
Ortho Clinical Diagnostics Reports Fourth Quarter and Fiscal Year ... - GlobeNewswire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. 238 (M)
Shares Float 119 (M)
% Held by Insiders 0.3 (%)
% Held by Institutions 98.3 (%)
Shares Short 7,020 (K)
Shares Short P.Month 6,800 (K)

Stock Financials

EPS -0
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.87
Profit Margin (%) -0.1
Operating Margin (%) 8.4
Return on Assets (ttm) 3.2
Return on Equity (ttm) -0.2
Qtrly Rev. Growth -1.3
Gross Profit (p.s.) 4.37
Sales Per Share 8.58
EBITDA (p.s.) 1.89
Qtrly Earnings Growth 0
Operating Cash Flow 293 (M)
Levered Free Cash Flow 400 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0.4
Price to Book value 9.42
Price to Sales 2.05
Price to Cash Flow 14.32

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.